Contract analysis

I. INSTRUCTIONS AND LEGEND This Claim Amendment Comparison Chart has been prepared as an internal working exhibit to accompany the draft Response to Non-Final Office Action in U.S. Application No. 17/851,216. The chart is intended to facilitate review by the prosecution team, outside technical advisors, and client representatives prior to finalization and filing of the formal amendment with the United States Patent a

1. U.S. Patent No. 10,537,418 ("the '418 patent") — Vantage Cryosurgical Systems, Inc. — Directed to a single-zone cryoablation balloon catheter system.

2. U.S. Patent No. 9,861,432 ("the '432 patent") — Vantage Cryosurgical Systems, Inc. — Directed to a cryoablation catheter with single-zone cooling and without impedance feedback functionality.

3. U.S. Published Application No. 2019/0183567 ("the '567 publication") — Helios Surgical Technologies, Inc. — Directed to a general cryoablation method and system, without zone-specific electrode integration or variable-zone cooling architecture. Parent Specification. All amendments are supported by the specification as originally filed, which is identical in all material respects to the disclosure of U.S. Patent No

II. SUMMARY OF REJECTIONS AND AMENDMENT STRATEGY A. Summary of Office Action Rejections and Objections The Non-Final Office Action mailed September 15, 2024 sets forth the following rejections and objections: B. Amendment Strategy Overview The proposed amendments are designed to address each category of rejection and objection identified above while preserving the broadest commercially meaningful claim scope for Sols

III. CLAIM AMENDMENT COMPARISON TABLE A. Claims 1–8 (§ 103 Rejection Group) Claim 1 (Independent — Substantive Amendment). Original Claim 1 (Currently Pending): 1\. A cryoablation catheter system comprising: an elongate catheter body having a proximal end and a distal end; a cryoablation element disposed at the distal end configured to deliver cryogenic fluid to target tissue; a plurality of impedance mapping electro

IV. SUMMARY TABLE OF AMENDMENTS The following table provides a consolidated summary of all proposed claim amendments, organized by claim number, with the applicable rejection or objection, type of amendment, key limitation(s) added, and specification support references.

V. CERTIFICATION AND SIGNATURE BLOCK This Claim Amendment Comparison Chart has been prepared in connection with the prosecution of U.S. Application No. 17/851,216 (SBD-001-CON2) on behalf of Solstice Biomedical Devices Ltd. and is submitted for internal review as a draft exhibit to the proposed Response to Non-Final Office Action mailed September 15, 2024. This document is a privileged and confidential attorney work